Preclinical Prostate Cancer Models

In vitro and in vivo models of prostate cancer for translational preclinical research and drug discovery
prostate-cancer-header.png

Advanced Drug Development with Translational Models of Prostate Cancer

Prostate cancer is a highly heterogeneous and complex disease, presenting serious challenges to preclinical drug development and biomedical research. Our suite of prostate cancer models helps you recapitulate all phases of disease progression and evaluate potential therapies for each, so your team can advance into clinical trials with confidence.

Prostate Cancer Cell Lines 

Cell Line Derived Xenograft Models 

Patient-Derived Xenograft Models 

Prostate Cancer Immunotherapy Assessment 

Open Prostate Cancer Model Databases 


Additional Prostate Cancer Resources

WHITE PAPER

New Advancements in Preclinical Prostate Cancer PDX Models
>> Read Now
   

WEBINAR

Patient-Derived Xenografts: New Advancements in Preclinical Prostate Cancer Models
>> Watch Now
   
progression of prostate cancer from initiation to metastatic, castration resistant disease, including genetic alterations and cellular processes

BLOG

Why Are Prostate Cancer Preclinical Models Hard to Develop?
>> Read Now
   
immunohistochemistry images showing that prostate cancer pdx models retain the structure of original patient tumors

BLOG

Prostate Cancer Patient-Derived Xenograft (PDX) Models
>> Read Now
   

POSTER

Prostate Cancer Patient-Derived Xenograft and Cell Line Model Validation
>> Read Now

Discuss Your Prostate Cancer Project